Valuation: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Market Cap 25.03B 3.75B 3.42B 3.16B 2.86B 5.37B 350B 5.62B 38.24B 15.17B 189B 14.07B 13.78B 600B P/E 2026 *
28.5x
P/E 2027 * 24.8x
Enterprise Value 25.03B 3.75B 3.42B 3.16B 2.86B 5.37B 350B 5.62B 38.24B 15.17B 189B 14.07B 13.78B 600B EV / Sales 2026 *
5.08x
EV / Sales 2027 * 4.68x
Free-Float
31.71%
Yield 2026 *
-
Yield 2027 * -
1 day-0.39%
1 week-4.10%
Current month-5.33%
1 month-6.77%
3 months+7.01%
6 months-11.95%
Current year-16.37%
1 week 37.89
Extreme 37.89000000
39.65
1 month 37.89
Extreme 37.89000000
43.42
Current year 33.83
Extreme 33.83
48.2
1 year 33.83
Extreme 33.83
48.2
3 years 23.4
Extreme 23.4
50.97
5 years 17.98
Extreme 17.98
56.26
10 years 11.8
Extreme 11.8
56.26
Manager TitleAgeSince
Chief Executive Officer 56 04/09/2026
Director of Finance/CFO 42 -
Corporate Officer/Principal 56 -
Director TitleAgeSince
Director/Board Member 56 15/05/2019
Chairman 55 06/09/2021
Director/Board Member 55 10/12/2021
Date Insider Type Main position Quantity % Market Cap. Importance
08/01/20 Buy

Company Secretary

30,000 0.0053%
08/01/20 Buy

Chief Technology Officer

70,000 0.0124%
08/01/20 Buy 70,000 0.0124%
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-4.10%-17.97%+23.54% 3.77B
-2.29%-5.34%+28.73%+128.34% 1,232B
-2.04%-5.78%+31.91%+78.34% 656B
-0.86%-3.71%+21.74%+105.02% 506B
-1.04%-1.80%+28.69%+68.01% 382B
-3.61%-9.62%+39.73%+30.53% 340B
-3.22%-5.20%+24.48%+51.30% 294B
-2.51%-4.49%-2.15%+29.67% 278B
-1.14%-6.05%+28.16%+65.35% 240B
-1.45%-0.85%+30.03%+120.72% 210B
Average -1.86%-2.45%+21.33%+70.08% 414B
Weighted average by Cap. -2.04%-2.67%+26.89%+87.75%

Financials

2026 *2027 *
Net sales 4.93B 739M 673M 623M 564M 1.06B 69B 1.11B 7.53B 2.99B 37.28B 2.77B 2.71B 118B 5.35B 802M 730M 676M 612M 1.15B 74.87B 1.2B 8.17B 3.24B 40.46B 3.01B 2.94B 128B
Net income 1.04B 155M 141M 131M 118M 222M 14.5B 233M 1.58B 628M 7.83B 582M 570M 24.81B 1.18B 177M 162M 150M 135M 254M 16.57B 266M 1.81B 717M 8.95B 666M 652M 28.36B
Net Debt - -
Projected Income Statement - Annual - Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Logo Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a China-based company principally engaged in the research, development, manufacturing and retail of Chinese herbal medicines, Chinese patent medicines, chemical raw materials and preparations, and nutritional health products. The Company operates its businesses through three segments. The Chinese Patent Medicine segment is mainly engaged in the research, development, manufacturing and sales of Chinese medicines, including Su Xiao Jiu Xin Pill, Jing Wan Hong Ruan Gao, An Gong Niu Huang Pill, Qing Gong Shou Tao Pill and other products. The Western Medicine segment is mainly engaged in the research, development, manufacturing and sales of Western medicines. The Others segment mainly includes economic information consulting services, house leasing and other businesses. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
3,890
Date Price Change Volume
19/11/26 CN¥38.15 -0.39% 3,495,147
18/11/26 CN¥38.30 -0.91% 3,610,110
17/11/26 CN¥38.65 -0.80% 4,365,227
16/11/26 CN¥38.96 -1.74% 5,481,867
13/11/26 CN¥39.65 -0.33% 3,825,883
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
38.15
Average target price
-

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
  1. Stock Market
  2. Stocks
  3. 600329 Stock